Adenovirus type 7 vaccine live

Generic Name: Adenovirus type 7 vaccine live

Brand Names: Adenovirus Type 4 and Type 7 Vaccine, Live

Drug Type: Biotech

Unique Ingredient Identifier: TM54L796SN

Clinical Trials

A Phase 2 Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Adult Patients with Active Mild to Moderate Ulcerative Colitis

Phase 2

Not yet recruiting

Conditions: Ulcerative Colitis (UC)

Interventions: Drug: Live SK08 powder
Drug: Placebo

First Posted Date: 2024-12-09

Last Posted Date: 2024-12-16

Lead Sponsor: Guangzhou Zhiyi Biotechnology Co., Ltd.

Target Recruit Count: 60

Registration Number: NCT06725017

Revealing Protective Immunity to Influenza Using Systems Immunology

Phase 4

Recruiting

Conditions: Influenza

Interventions: Biological: Live Attenuated Influenza Vaccine

First Posted Date: 2024-07-15

Last Posted Date: 2024-10-16

Lead Sponsor: Emory University

Target Recruit Count: 50

Registration Number: NCT06501963

Locations: 🇺🇸
Hope Clinic of the Emory Vaccine Center, Decatur, Georgia, United States

A Study to Evaluate the Efficacy and Safety of Live SK08 Powder in Patients With IBS-D

Phase 3

Recruiting

Conditions: Irritable Bowel Syndrome With Diarrhea

Interventions: Drug: Live SK08 powder
Drug: Placebo

First Posted Date: 2024-02-07

Last Posted Date: 2025-04-03

Lead Sponsor: Guangzhou Zhiyi Biotechnology Co., Ltd.

Target Recruit Count: 1298

Registration Number: NCT06247046

Locations: 🇨🇳
Wuxi People's Hospital, Wuxi, Jiangsu, China
🇨🇳
Binzhou Medical University Hospital, Binzhou, Shandong, China

Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy

Not Applicable

Recruiting

Conditions: Gastric Cancer
Neoadjuvant Chemotherapy

Interventions: Drug: live combined Bifidobacteriun, Lactobacillus and Enterococcus capsules

First Posted Date: 2023-06-13

Last Posted Date: 2023-06-13

Lead Sponsor: The Affiliated Hospital of Qingdao University

Target Recruit Count: 318

Registration Number: NCT05901779

Locations: 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China

Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa

Phase 3

Active, not recruiting

Conditions: Meningococcal Immunisation
Healthy Volunteers

Interventions: Biological: Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
Biological: Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Biological: Pneumoccocal Vaccine
Biological: Oral bivalent types 1 and 3; Poliomyelitis Vaccine (OPV)
Biological: Measles, Mumps, and Rubella Vaccine live (MMR)
Biological: DTwP-HepB-Hib-IPV vaccine
Biological: DTaP-IPV-Hib-HepB vaccine
Biological: Rotavirus vaccine
Biological: Hepatitis A vaccine
Biological: Measles vaccine
Biological: Varicella vaccine live
Biological: Typhoid conjugate vaccine (TCV)

First Posted Date: 2023-04-03

Last Posted Date: 2024-11-27

Lead Sponsor: Sanofi Pasteur, a Sanofi Company

Target Recruit Count: 1528

Registration Number: NCT05794230

Locations: 🇮🇳
Investigational Site Number : 3560006, Chennai, India
🇮🇳
Investigational Site Number : 3560007, Hyderabad, India
🇮🇳
Investigational Site Number : 3560016, Kanpur, India

and more 12 locations

Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis

Phase 3

Not yet recruiting

Conditions: Immunoglobulin Light-chain Amyloidosis

Interventions: Drug: Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab
Drug: Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab

First Posted Date: 2023-03-20

Last Posted Date: 2023-03-20

Lead Sponsor: Air Force Military Medical University, China

Target Recruit Count: 116

Registration Number: NCT05776940

The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis

Phase 2

Recruiting

Conditions: Probiotics
Glutamine
Bifidobacterium
Radiation Proctitis
Gut Microbiota

Interventions: Drug: Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules

First Posted Date: 2022-06-07

Last Posted Date: 2022-07-15

Lead Sponsor: West China Hospital

Target Recruit Count: 176

Registration Number: NCT05406882

Locations: 🇨🇳
West China Hospital, Chengdu, Sichuan, China
🇨🇳
Xin Wang, Chengdu, Sichuan, China

Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease

Phase 4

Conditions: Colonoscopy
Probiotics
Functional Constipation
Irritable Bowel Syndrome

Interventions: Drug: Live Combined Bifidobacterium and Lactobacillus
Drug: Normal saline
Drug: Basic treatment

First Posted Date: 2022-05-09

Last Posted Date: 2022-08-04

Lead Sponsor: First Affiliated Hospital Xi'an Jiaotong University

Target Recruit Count: 160

Registration Number: NCT05366335

Locations: 🇨🇳
First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China

A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma

Phase 4

Recruiting

Conditions: Bladder Urothelial Carcinoma

Interventions: Drug: Live Combined (Bifidobacterium,Lactobacillus and Enterococcus Capsules)

First Posted Date: 2022-02-02

Last Posted Date: 2022-02-02

Lead Sponsor: Tianjin Medical University Second Hospital

Target Recruit Count: 190

Registration Number: NCT05220124

Locations: 🇨🇳
Tianjin Medical University Second Hospital, Tianjin, Tianjin, China

Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease

Phase 4

Recruiting

Conditions: Neurodegenerative Diseases
Parkinsonian Disorders
Basal Ganglia Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Parkinson Disease
Movement Disorders

Interventions: Drug: Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules
Other: Placebo

First Posted Date: 2021-05-04

Last Posted Date: 2023-02-21

Lead Sponsor: Beijing Friendship Hospital

Target Recruit Count: 240

Registration Number: NCT04871464

Locations: 🇨🇳
China-Japan Friendship Hospital, Beijing, Beijing, China
🇨🇳
Beijing Friendship Hospital, Beijing, Beijing, China
🇨🇳
Jinan Central Hospital, Jinan, Shandong, China

and more 7 locations

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy